Cormorant Asset Management, LP, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), bought 588,235 shares at $17.00 ($10.0M) on 2023-12-08, disclosed to the SEC on 2023-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |